Prometheus Therapeutics Inc. research brief
CIK 1823161
Generated Nov. 18, 2026, 9:21 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: MIRAMAR Florida. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- April 15, 2026 · D/A · 0001823161-26-000001 · Source evidence
Reported offering amount: 6500000 USD. Reported amount sold: 2745000 USD.
- Nov. 12, 2025 · D · 0001823161-25-000002 · Source evidence
Reported offering amount: 5000000 USD. Reported amount sold: 130000 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Prometheus Therapeutics Inc. research brief,” CIK 1823161, retrieved Nov. 18, 2026, 9:21 p.m.. Cite the specific accessions used. No amounts have been summed.